Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 28519 [2014-11353]

Download as PDF Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices 28519 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Expansion of WebPlus Tool to Retrieve Cancer Registry Data for use in Treatment Summaries for Cancer Survivors, Special Interest Projects (SIP)14–016; and Translating and Communicating the Science of Breast Cancer Prevention, SIP14–019, Panel J, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: The meeting announced below concerns Integrating Self-Management Training with Cancer Survivorship Care Planning, Special Interest Projects (SIP)14–015; Utilizing Data Linkages to Populate Treatment Summaries for Cancer Survivors, SIP14–017; and Skin Cancer Prevention: Finding Messages that Work to Reduce Incidental and Intentional UV Exposure SIP14–018, Panel B1, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: EMCDONALD on DSK67QTVN1PROD with NOTICES Time and Date: 10:00 a.m.–5:00 p.m., June 5, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Expansion of WebPlus Tool to Retrieve Cancer Registry Data for use in Treatment Summaries for Cancer Survivors, SIP14–016; and Translating and Communicating the Science of Breast Cancer Prevention, SIP14–019, Panel J, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2014–11360 Filed 5–15–14; 8:45 am] BILLING CODE 4163–18–P Time and Date: 9:00 a.m.–6:00 p.m., June 3, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Integrating Self-Management Training with Cancer Survivorship Care Planning, SIP14–015; Utilizing Data Linkages to Populate Treatment Summaries for Cancer Survivors, SIP14–017; and Skin Cancer Prevention: Finding Messages that Work to Reduce Incidental and Intentional UV Exposure SIP14–018, Panel B1, initial review.’’ Contact Person for More Information: Diana Bartlett, M.P.H., M.P.P., Health Scientist, CDC, 1600 Clifton Road, NE., Mailstop D–72, Atlanta, Georgia 30333, Telephone: (404) 639–4938, ZXD5@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–11354 Filed 5–15–14; 8:45 am] BILLING CODE 4163–18–P VerDate Mar<15>2010 20:00 May 15, 2014 Jkt 232001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 The meeting announced below concerns Healthy Brain Initiative Research Network (HBIN)— Coordinating Center, Special Interest Projects (SIP) 14–001, and Healthy Brain Initiative Network, (HBIN)— Collaborating Centers, SIP 14–002, Panel F, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 9:30 a.m.–5:00 p.m., June 2, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Healthy Brain Initiative Research Network (HBIN)—Coordinating Center, SIP 14–001, and Healthy Brain Initiative Network (HBIN)—Collaborating Centers, SIP 14–002 Panel F, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–11353 Filed 5–15–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Workplace Health Research E:\FR\FM\16MYN1.SGM 16MYN1

Agencies

[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Page 28519]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11353]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Healthy Brain Initiative 
Research Network (HBIN)--Coordinating Center, Special Interest Projects 
(SIP) 14-001, and Healthy Brain Initiative Network, (HBIN)--
Collaborating Centers, SIP 14-002, Panel F, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 9:30 a.m.-5:00 p.m., June 2, 2014 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Healthy Brain Initiative Research Network (HBIN)--
Coordinating Center, SIP 14-001, and Healthy Brain Initiative 
Network (HBIN)--Collaborating Centers, SIP 14-002 Panel F, initial 
review.''
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop 
F-80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, 
EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-11353 Filed 5-15-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.